| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |